Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Vera Bradley Boosts Q4, FY13 Outlook

RELATED NEWS
Trade VRA now with 

Vera Bradley, Inc. (VRA: Quote), which makes stylish and functional accessories for women, on Tuesday raised its revenue and earnings outlook for the fourth quarter and fiscal year 2013.

The company said it now expects fourth quarter net revenues to be in a range of $149 million to $154 million, compared to its prior guidance of $147 million to $152 million.

Fourth quarter indirect net revenues are now expected to grow in the low- to mid-single digits, compared to the company's previous guidance of low-single digits and same-store sales are now expected to be flat compared to the prior year versus previous guidance of low-single digit growth, mainly due to lower-than-expected traffic during the holiday season.

The company now expects fourth quarter gross margin to increase about 140 basis points year-over-year, compared to its prior expectation of 130 basis points. As a result, the company raised its fourth quarter earnings outlook to a range of $0.56 to $0.58 per share from its prior outlook of $0.55 to $0.57 per share.

Analysts polled by Thomson Reuters currently expect the company to earn $0.56 per share on revenue of $151.54 million for the fourth quarter. "We are pleased with how our customers have responded to our brand during the fourth quarter," commented Michael Ray, Vera Bradley's Chief Executive Officer. "While traffic in our comparable store base was a bit softer than expected, we believe our overall sales performance demonstrates the benefits of our multi-channel retail model."

For fiscal 2013, the company now forecasts net revenues of $528 million to $533 million and earnings of $1.64 to $1.66 per share. Previously, the company forecast net revenue of $526 million to $531 million and earnings of $1.63 to $1.65 per share.

Analysts currently expect the company to earn $1.64 per share on revenue of $530.23 million for the fiscal year 2013.

Vera Bradley shares closed Tuesday's regular trading session at $23.00, up 41 cents or 1.81%, and gained an additional $1.49 or 6.48% in after hours trading.

Register
To receive FREE breaking news email alerts for Vera Bradley, Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.